8Hammerman C, Shchors I, Jacobson S, et al. Ibuproten versus continuous indomethacin in premature neonates with patent ductus arteriosus:Is the difference in the mode of administration [ J ] ? Pediatr Res, 2008,64 (3) :291 -297.
9Pai VB, Sakadjian A, Puthoff TD. Ibuprofen lysine for the prevention and treatment of patent ductas arteriosas [ J ]. Pharmacotherapy, 2008,28 (9) :1162 - 1182.
10Su BH, Lin HC, Chiu HY, et al. Comparison of ibuprofen and indometacin for early - targeted treatment of patent ductus arteriosus in extremely premature infants:A randomised controlled trial[ J/OL]. Arch Dis Child Fetal Neonatal Ed,2008,93 (2) :94 - 99.
6Hladik A, Lynshue K. Dyshemoglobinemias andpulse oximetry : A thera- peutic challenge[ J]. Pediatr Hematd Oncol,2008,30( 11 ) :850 - 852.
7Meberg A,Andreassen A, Brunvand L,et al. Pulse oximetry screening as a complementary strategy to detect critical congenital heart defects [ J l- Acta Paediatr,2009,98 (4) :682 - 66.
8Subbe CP, Kruger M, Rutherford P, et al. Validation of a modified Early Warning Score in medical admissions [ J] . QJM, 2001, 94 (10) : 521-526.
9Roland D, Madar J, Connolly G. The Newborn Early Warning (NEW)system: development of an at-risk infant intervention system [J] . Infant, 2000, 6 (4) : 116-120.
